MEDS — Trxade Health Cashflow Statement
0.000.00%
- $20.73m
- $17.23m
- $8.27m
- 45
- 59
- 82
- 65
Annual cashflow statement for Trxade Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.284 | -2.54 | -5.32 | -2.4 | -13.7 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1.09 | 3.91 | 1.66 | 0.568 | 5.15 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.668 | -3.6 | 1.08 | 0.258 | 5.66 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 0.142 | -2.21 | -2.57 | -1.56 | -2.07 |
Capital Expenditures | -0.082 | -0.038 | -0.023 | — | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.25 | — | — | -0.428 | -0.276 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.332 | -0.038 | -0.023 | -0.428 | -0.276 |
Financing Cash Flow Items | — | -0.732 | 0 | -0.167 | 1.15 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.19 | 5.3 | -0.208 | -0.035 | 1.41 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2 | 3.05 | -2.8 | -2.03 | -0.943 |